BioCryst to Present at 43rd Annual J.P. Morgan Healthcare Conference
BioCryst Pharmaceuticals (Nasdaq: BCRX) has announced its upcoming presentation at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation is scheduled for Tuesday, January 14, 2025, at 6:00 p.m. ET. Interested parties can access both the live audio webcast and a replay of the presentation through the Investors & Media section on BioCryst's official website (www.biocryst.com).
BioCryst Pharmaceuticals (Nasdaq: BCRX) ha annunciato la sua prossima presentazione alla 43ª Conferenza Annuale J.P. Morgan sulla Salute a San Francisco. La presentazione è programmata per martedì 14 gennaio 2025, alle 18:00 ET. Le parti interessate possono accedere sia alla diretta audio in streaming che alla registrazione della presentazione attraverso la sezione Investitori & Media sul sito ufficiale di BioCryst (www.biocryst.com).
BioCryst Pharmaceuticals (Nasdaq: BCRX) ha anunciado su próxima presentación en la 43ª Conferencia Anual de J.P. Morgan sobre Salud en San Francisco. La presentación está programada para el martes 14 de enero de 2025, a las 6:00 p.m. ET. Las partes interesadas pueden acceder tanto a la transmisión en vivo de audio como a la reproducción de la presentación a través de la sección de Inversores y Medios en el sitio web oficial de BioCryst (www.biocryst.com).
BioCryst 제약 (Nasdaq: BCRX)가 샌프란시스코에서 열리는 제43회 연례 J.P. 모건 헬스케어 컨퍼런스에서 발표할 예정이라고 발표했습니다. 발표는 2025년 1월 14일 화요일, 오후 6시 ET로 예정되어 있습니다. 관심 있는 분들은 BioCryst 공식 웹사이트(www.biocryst.com)의 투자자 및 미디어 섹션을 통해 생중계 오디오 웹캐스트와 발표의 다시보기를 이용할 수 있습니다.
BioCryst Pharmaceuticals (Nasdaq: BCRX) a annoncé sa prochaine présentation lors de la 43e Conférence Annuelle J.P. Morgan sur la Santé à San Francisco. La présentation est prévue pour mardi 14 janvier 2025, à 18h00 ET. Les parties intéressées peuvent accéder à la fois à la diffusion audio en direct et à un replay de la présentation dans la section Investisseurs & Médias sur le site officiel de BioCryst (www.biocryst.com).
BioCryst Pharmaceuticals (Nasdaq: BCRX) hat seine bevorstehende Präsentation auf der 43. jährlichen J.P. Morgan Healthcare-Konferenz in San Francisco angekündigt. Die Präsentation ist für Dienstag, den 14. Januar 2025, um 18:00 Uhr ET geplant. Interessierte Parteien können sowohl auf den Live-Audio-Webcast als auch auf die Wiederholung der Präsentation über den Bereich Investoren & Medien auf der offiziellen Website von BioCryst (www.biocryst.com) zugreifen.
- None.
- None.
RESEARCH TRIANGLE PARK, N.C., Jan. 07, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2025, at 6:00 p.m. ET.
Link to the live audio webcast and replay of the presentation may be accessed in the Investors & Media section of BioCryst’s website at www.biocryst.com.
About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals is a global biotechnology company with a deep commitment to improving the lives of people living with hereditary angioedema and other rare diseases. BioCryst leverages its expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of small-molecule and protein therapies. For more information, please visit www.biocryst.com or follow us on LinkedIn.
BCRXW
Contact:
John Bluth
+1 919 859 7910
jbluth@biocryst.com
FAQ
When is BioCryst (BCRX) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors access BioCryst's (BCRX) J.P. Morgan Healthcare Conference presentation?
Which annual J.P. Morgan Healthcare Conference will BCRX present at in 2025?
Where will the 2025 J.P. Morgan Healthcare Conference featuring BCRX take place?
